Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
59,564,593
-
Share change
-
-1,366,937
-
Total reported value
-
$5,707,577,717
-
Put/Call ratio
-
245%
-
Price per share
-
$95.87
-
Number of holders
-
431
-
Value change
-
-$130,898,195
-
Number of buys
-
218
-
Number of sells
-
168
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2018
As of 30 Sep 2018,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
431 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,564,593 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BANK OF AMERICA CORP /DE/, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, UBS Group AG, DEUTSCHE BANK AG\, WELLS FARGO & COMPANY/MN, and Rafferty Asset Management, LLC.
This page lists
431
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.